Phase 1/1b dose escalation and expansion study of BEZ235, a dual PI3K/mTOR inhibitor, in patients with advanced solid tumors including patients with advanced breast cancer.
Cancer Chemother Pharmacol
; 82(2): 285-298, 2018 08.
Article
em En
| MEDLINE
| ID: mdl-29882016
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quinolinas
/
Neoplasias da Mama
/
Imidazóis
/
Neoplasias
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article